Acasti Pharma Inc. (ACST)

NASDAQ: ACST · IEX Real-Time Price · USD
1.39
0.06 (4.51%)
At close: Jan 14, 2022 4:00 PM
1.35
-0.04 (-2.88%)
After-hours:Jan 14, 2022 7:38 PM EST
Market Cap62.31M
Revenue (ttm)196,000
Net Income (ttm)-11.00M
Shares Out44.83M
EPS (ttm)-0.46
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume700,848
Open1.30
Previous Close1.33
Day's Range1.30 - 1.43
52-Week Range1.04 - 9.76
Beta1.42
AnalystsHold
Price Target2.21 (+59.0%)
Earnings DateNov 10, 2021

About ACST

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre, an omega-3 phospholipid therapeutic to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.

IndustryPharmaceuticals
CEOJanelle D'Alvise
Employees32
Stock ExchangeNASDAQ
Ticker SymbolACST
Full Company Profile

Financial Performance

Financial numbers in millions CADFinancial Statements

Analyst Forecast

According to one analyst, the rating for Acasti Pharma stock is "Hold" and the 12-month stock price forecast is 2.21.

Price Target
$2.21
(59.01% upside)
Analyst Consensus: Hold

News

Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference

LAVAL, Québec, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D'Alvise, President and CEO of Acasti, will be pr...

1 week ago - GlobeNewsWire

ACST Stock Price Predictions: Why One Analyst Sees Acasti Rocketing to $6

After an Oppenheimer upgrade, shares of ACST stock are soaring higher by more than 25%. Why exactly is the investment firm bullish?

3 weeks ago - InvestorPlace

Best Penny Stocks to Watch as the Market Takes a Bullish Turn

Are any of these penny stocks on your watchlist right now? The post Best Penny Stocks to Watch as the Market Takes a Bullish Turn appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...

Other symbols:IAGMETX
3 weeks ago - PennyStocks

See Why Acasti Pharma Shares Are Trading Over 20% Higher?

Oppenheimer initiated coverage of Acasti Pharma Inc (NASDAQ: ACST) with an Outperform rating and $6 price target. The analyst sees over 400% upside for the stock.

3 weeks ago - Benzinga

Acasti Pharma's Hemorrhage Candidate Shows Encouraging PK Profile In Healthy Volunteers

Acasti Pharma Inc (NASDAQ: ACST) has announced interim results from its pivotal pharmacokinetic (PK) bridging study of GTX-104 for Subarachnoid Hemorrhage. Based on an interim analysis of the first 20 o...

1 month ago - Benzinga

Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104

Bioavailability of GTX-104 compares favorably with the oral formulation of nimodipine; full PK study expected to report out as planned in H1'22 Bioavailability of GTX-104 compares favorably with the ora...

1 month ago - GlobeNewsWire

Acasti Pharma CEO to Participate in the Benzinga All Access Event on December 2nd

LAVAL, Québec, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan D'Alvise, President and CEO of Acasti Pharma, wil...

1 month ago - GlobeNewsWire

Acasti Pharma Announces Annual Stock Option Grants

LAVAL, Québec, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced the annual grant of stock options to its employees, execut...

2 months ago - GlobeNewsWire

Acasti Pharma To Present At The Q4 Investor Summit on November 16th

Laval, Quebec--(Newsfile Corp. - November 11, 2021) - Acasti Pharma Inc. (NASDAQ: ACST) (TSXV: ACST) ("Acasti" or the "Company"), today announced that management will present at the Q4 Investor Summit, ...

2 months ago - Newsfile Corp

Acasti Pharma Schedules Second Quarter Fiscal 2022 Business Update Conference Call

Call to be held on Wednesday, November 10th at 1:00 PM Eastern Time Call to be held on Wednesday, November 10th at 1:00 PM Eastern Time

2 months ago - GlobeNewsWire

Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan

Patents strengthen Acasti's IP portfolio and provide protection through 2036 and 2037, respectively Patents strengthen Acasti's IP portfolio and provide protection through 2036 and 2037, respectively

3 months ago - GlobeNewsWire

Acasti Pharma Announces Initiation of Pharmacokinetic Bridging Study for GTX-104, the Company's Lead Drug Candidate f...

Study expected to be completed in the first half of 2022, with the goal to commence the Phase 3 safety study in the second half of 2022 Study expected to be completed in the first half of 2022, with the...

3 months ago - GlobeNewsWire

Acasti Pharma Provides Update Following Acquisition of Grace Therapeutics and Regains Compliance with Nasdaq Listing ...

LAVAL, Québec, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today provided a business update and announced that the Nasdaq Stock Mark...

3 months ago - GlobeNewsWire

Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21ˢᵗ

LAVAL, Québec, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that it will be presenting at the Oppenheimer Fall Health...

4 months ago - GlobeNewsWire

Why Shares of Acasti Pharma Slumped Tuesday

The clinical-stage pharmaceutical company completed its merger with Grace Therapeutics last week.

4 months ago - The Motley Fool

Acasti Pharma Announces Successful Completion of its Merger with Grace Therapeutics, Inc., Voting Results of its Annu...

LAVAL, Québec, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti”) (NASDAQ: ACST–TSX-V: ACST), announced today the completion of its previously disclosed acquisition of Grace Therapeutics, I...

4 months ago - GlobeNewsWire

Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022

August 4 th webcast replay discussing planned acquisition of Grace Therapeutics  available on the Company's website

5 months ago - GlobeNewsWire

Reminder: Acasti Pharma to Host Conference Call on August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace T...

LAVAL, Québec, July 29, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) announces a reminder that it will host a business update conference call on...

5 months ago - GlobeNewsWire

Best Penny Stocks to Buy in August? 4 for Your Watchlist

Which penny stocks are investors watching with August only a week away? The post Best Penny Stocks to Buy in August?

Other symbols:CFMSHMYNAK
5 months ago - PennyStocks

Acasti Pharma Schedules Conference Call for August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeu...

All shareholders are strongly encouraged to vote in advance of the August 26, 2021, annual and special meeting of shareholders All shareholders are strongly encouraged to vote in advance of the August 2...

5 months ago - GlobeNewsWire

Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist

Biotech penny stocks are in focus; here's 4 to watch right now The post Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other symbols:CHEKSEELWORX
6 months ago - PennyStocks

5 Hot Penny Stocks You Need to Know About in 2021

Are these top penny stocks worth watching in July 2021? The post 5 Hot Penny Stocks You Need to Know About in 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:DSSJOBMETXNGD
6 months ago - PennyStocks

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Acasti Pharma, Inc. - ACST

NEW YORK, July 3, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action ...

6 months ago - PRNewsWire

Best Biotech Penny Stocks In Summer 2021? 7 For Your Watchlist

Are these the best biotech penny stocks to watch right now? The post Best Biotech Penny Stocks In Summer 2021?

Other symbols:ADMPAMPEBIOLJAGXNWBO
6 months ago - PennyStocks

What Penny Stocks to Buy Today? 7 Small-Caps to Watch Right Now

Which penny stocks are on your watchlist today? Here's 7 for some inspiration The post What Penny Stocks to Buy Today?

Other symbols:AHTBBIGBESTFAMIIDEX
6 months ago - PennyStocks